Stock Report

All about this stock under one free report Last Updated: 01-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Procter & Gamble Health Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: PGHL | BSE: 500126

₹5,781.00

up-down-arrow ₹13.00 (0.23%)

As on 01-Sep-2026 12:24IST

Market cap

info icon

₹9,512 Cr

Revenue (TTM)

info icon

₹1,433 Cr

P/E Ratio

info icon

26.7

P/B Ratio

info icon

15.5

Div. Yield

info icon

3.6 %

Edit peer-selector-edit
Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Market cap (₹ Cr)
 9,512 21,304 19,467 17,947 17,350
Revenue (₹ Cr)
 1,433 2,570 2,287 3,230 2,432
Net Profit (₹ Cr)
 356.88 735.15 678.07 666.92 169.62
Net Margin (%)
 24.61 26.88 28.10 20.60 6.90
RoE (%)
 58.24 19.16 19.73 18.75 20.76
Price to Earnings
 26.65 28.98 29.26 27.87 102.29
Price-To-Book
 15.45 4.83 5.17 4.44 19.19

Income Statement (₹ Cr)

Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Operating Revenue arrow
1,407.97 2,519.65 1,694.10 2,009.15 2,275.58
Total Income arrow
1,428.99 2,707.60 1,761.04 2,032.97 2,304.07
Total Expenditure arrow
954.99 1,615.47 1,142.66 1,334.32 2,013.55
EBITDA arrow
452.98 904.18 551.44 674.83 262.03
Depreciation arrow
23.59 57.73 53.44 182.51 28.58
EBIT arrow
429.39 846.45 498.00 492.32 233.45
Interest arrow
0.55 9.57 0.78 84.80 4.49
Other Income arrow
21.02 187.95 66.94 23.82 28.49
Exceptional Items arrow
-20.19 -49.16 -- -- -5.25
Profit before Tax arrow
449.86 975.67 564.43 431.34 252.20
Provision for Tax arrow
122.95 253.24 103.01 34.22 64.68
Profit after Tax arrow
326.91 722.43 461.42 397.12 187.52

Liabilities (₹ Cr)

Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Shareholder's Funds arrow
524.55 4,202.90 2,315.71 2,586.18 872.79
Minority Interest arrow
-- -- 31.12 635.91 --
Non-Current Liabilities arrow
31.17 19.19 7.89 979.35 394.49
Current Liabilities arrow
254.93 627.48 330.85 2,608.96 1,109.50
Total Liabilities arrow
841.35 4,921.88 2,698.12 6,810.40 2,414.58

Assets (₹ Cr)

Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Non-Current Assets arrow
254.39 1,046.35 792.65 4,431.47 509.16
Current Assets arrow
556.26 3,803.22 1,892.92 2,378.93 1,859.88
Total Assets arrow
841.35 4,921.88 2,698.12 6,810.40 2,414.58
Total Debt* arrow
0.00 2.50 0.28 2,735.27 0.00
Net Current Assets arrow
301.33 3,175.74 1,562.07 -230.03 750.38
Contingent Liabilities arrow
174.73 370.49 0.64 53.95 121.23

Cashflow (₹ Cr)

Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Cash From Operating Activities arrow
337.79 967.57 318.39 486.01 -15.14
Cash Flow from Investing Activities arrow
1.26 -561.67 -320.04 -1,854.52 18.69
Cash from Financing Activities arrow
-343.92 -798.31 -38.07 1,379.68 -91.97
Net Cash Inflow / Outflow arrow
-4.87 -392.41 -39.72 11.17 -88.42

Ratios

Profitability Ratios

 Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
ROCE (%) arrow
84.86 23.39 26.92 12.37 31.24
ROE (%) arrow
62.18 17.16 22.97 16.64 23.02
ROA (%) arrow
41.65 14.91 18.98 7.72 8.90
EBIT Margin (%) arrow
33.67 43.34 36.50 34.77 12.77
Net Margin (%) arrow
22.88 26.68 26.20 19.53 8.14
Cash Profit Margin (%) arrow
22.36 29.72 30.39 27.41 9.47

Growth Ratios

 Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Revenue Growth (%) arrow
50.72 10.45 15.50 19.23 32.59
EBIT Growth (%) arrow
44.19 19.68 24.41 27.51 -1.38
Net Profit Growth (%) arrow
39.46 -5.88 22.40 6.14 62.02
EPS Growth (%) arrow
39.46 -5.88 21.40 2.58 62.02
Book Value Growth (%) arrow
-2.37 -0.34 24.37 17.69 13.51

Valuation Ratios

 Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Price / Earnings arrow
24.36 29.89 21.89 29.18 103.45
Price / Book Value arrow
15.33 5.14 4.49 4.43 22.39
Dividend Yield (%) arrow
4.27 1.59 0.38 0.00 0.46
EV/EBITDA arrow
16.41 16.93 15.41 18.29 65.23
Market Cap (₹ Cr) arrow
7,964.89 21,592.90 10,004.85 11,440.30 19,398.64

Solvency Ratios

 Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Debt to Equity arrow
0.00 0.00 0.00 1.06 0.00
Short term debt to equity ratio arrow
-- 0.00 0.00 0.51 --
Current Ratio arrow
2.18 6.06 5.72 0.91 1.68
Quick Ratio arrow
1.65 5.31 4.62 0.84 0.75
Interest Coverage arrow
818.93 102.95 724.63 6.09 57.17

Operating Efficiency Ratios

 Procter & Gamble Health Pfizer Caplin Point Lab Eris Lifesciences Astrazeneca Pharma
Debtors to sales (%) arrow
11.67 7.22 32.04 21.00 9.39
Asset Turnover arrow
2.00 0.54 0.70 0.41 1.08
Receivable days arrow
36.06 26.06 100.92 61.68 31.88
Inventory Days arrow
28.65 65.95 70.16 27.66 126.03
Payable days arrow
181.85 81.01 96.31 165.04 163.79
Cash Conversion Cycle arrow
-117.14 11.00 74.76 -75.70 -5.88
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...